PL2073008T3 - Ulepszone sposoby prowadzenia testów immunologicznych - Google Patents
Ulepszone sposoby prowadzenia testów immunologicznychInfo
- Publication number
- PL2073008T3 PL2073008T3 PL09004778T PL09004778T PL2073008T3 PL 2073008 T3 PL2073008 T3 PL 2073008T3 PL 09004778 T PL09004778 T PL 09004778T PL 09004778 T PL09004778 T PL 09004778T PL 2073008 T3 PL2073008 T3 PL 2073008T3
- Authority
- PL
- Poland
- Prior art keywords
- immunoassay methods
- improved immunoassay
- antibody
- improved
- relats
- Prior art date
Links
- 238000003018 immunoassay Methods 0.000 title 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000000090 biomarker Substances 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000022602 disease susceptibility Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68542205P | 2005-05-27 | 2005-05-27 | |
GB0510943A GB2426581A (en) | 2005-05-27 | 2005-05-27 | Immunoassay methods |
EP06744011A EP1889059B1 (en) | 2005-05-27 | 2006-05-26 | Improved immunoassay methods |
EP09004778A EP2073008B1 (en) | 2005-05-27 | 2006-05-26 | Improved immunoassay methods |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2073008T3 true PL2073008T3 (pl) | 2012-09-28 |
Family
ID=34834805
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL09004778T PL2073008T3 (pl) | 2005-05-27 | 2006-05-26 | Ulepszone sposoby prowadzenia testów immunologicznych |
PL06744011T PL1889059T3 (pl) | 2005-05-27 | 2006-05-26 | Uproszczone sposoby prowadzenia testów immunologicznych |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06744011T PL1889059T3 (pl) | 2005-05-27 | 2006-05-26 | Uproszczone sposoby prowadzenia testów immunologicznych |
Country Status (19)
Country | Link |
---|---|
US (1) | US8722339B2 (pl) |
EP (3) | EP2275815B1 (pl) |
JP (1) | JP4876127B2 (pl) |
KR (1) | KR101400986B1 (pl) |
CN (2) | CN102749447B (pl) |
AT (2) | ATE436018T1 (pl) |
AU (1) | AU2006250923B2 (pl) |
CA (1) | CA2609793C (pl) |
DE (1) | DE602006007703D1 (pl) |
DK (3) | DK2275815T3 (pl) |
ES (3) | ES2458105T3 (pl) |
GB (1) | GB2426581A (pl) |
MX (1) | MX2007014815A (pl) |
NO (1) | NO339224B1 (pl) |
PL (2) | PL2073008T3 (pl) |
PT (2) | PT2275815E (pl) |
RU (1) | RU2416095C2 (pl) |
SI (1) | SI2073008T1 (pl) |
WO (1) | WO2006126008A2 (pl) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
GB9810040D0 (en) | 1998-05-11 | 1998-07-08 | Univ Nottingham | Blood borne tumour markers |
GB9827228D0 (en) * | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
US20030232399A1 (en) * | 2000-06-14 | 2003-12-18 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
GB2395270B (en) | 2002-11-14 | 2006-08-16 | Univ Nottingham | Tumour marker proteins and uses thereof |
US7858323B2 (en) | 2004-06-09 | 2010-12-28 | The Regents Of The University Of Michigan | Phage microarray profiling of the humoral response to disease |
GB2426581A (en) | 2005-05-27 | 2006-11-29 | Univ Nottingham | Immunoassay methods |
SI1889059T1 (sl) | 2005-05-27 | 2009-12-31 | Oncimmune Ltd | Izboljšani imunotestni postopek |
US9347945B2 (en) * | 2005-12-22 | 2016-05-24 | Abbott Molecular Inc. | Methods and marker combinations for screening for predisposition to lung cancer |
CA2634797A1 (en) * | 2005-12-22 | 2007-07-05 | Abbott Laboratories | Methods and marker combinations for screening for predisposition to lung cancer |
CA2646329C (en) | 2006-03-20 | 2018-07-03 | The Regents Of The University Of California | Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
CA2663154C (en) * | 2006-09-13 | 2016-02-23 | Oncimmune Ltd | Improved immunoassay methods |
CN101632020B (zh) | 2006-09-13 | 2013-11-27 | 昂西免疫有限公司 | 改进的免疫测定方法 |
WO2008042508A1 (en) * | 2006-10-03 | 2008-04-10 | University Of Southern California | Grp78 as a predictor of responsiveness to therapeutic agents |
ES2530209T3 (es) * | 2007-02-23 | 2015-02-27 | Physicians Choice Laboratory Services, Llc | Métodos diagnósticos dirigidos a intervención clínica |
US8940298B2 (en) | 2007-09-04 | 2015-01-27 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection |
CN101925364B (zh) | 2007-11-27 | 2014-04-30 | 不列颠哥伦比亚大学 | 用于预防和治疗关节炎的14-3-3拮抗剂 |
GB0725239D0 (en) * | 2007-12-24 | 2008-02-06 | Oncimmune Ltd | Calibrator for autoantibody assay |
EP2623985A1 (en) * | 2008-02-21 | 2013-08-07 | Iris International, Inc. | Method for early determination of recurrence after therapy for prostate cancer |
CN102216772B (zh) * | 2008-09-19 | 2014-11-26 | 里奇维尤诊断公司 | 用于固体生物对象的分析的方法 |
EP2389585A2 (en) * | 2009-01-22 | 2011-11-30 | Li-Cor, Inc. | Single molecule proteomics with dynamic probes |
EP3495000A1 (en) | 2009-02-17 | 2019-06-12 | Cornell Research Foundation, Inc. | Methods and kits for diagnosis of cancer and prediction of therapeutic value |
BRPI1009573A2 (pt) * | 2009-03-11 | 2017-07-18 | Augurex Life Sciences Corp | método para avaliar uma condição artrítica em um sujeito, kit para detectar a presença de um auto-anticorpo, e, método para determinar o subtipo de artrite em um paciente. |
SG176962A1 (en) * | 2009-06-23 | 2012-01-30 | Eventus Diagnostics Israel Ltd | A method and system for the detection of cancer |
CN101762700A (zh) * | 2009-06-24 | 2010-06-30 | 北京科美东雅生物技术有限公司 | 一种定量检测血液中癌胚抗原的磁性免疫层析试纸条及制备方法 |
ES2711504T3 (es) | 2009-07-24 | 2019-05-06 | Rhode Island Hospital | Vacunas de células dendríticas para tumores que expresan asparaginil-beta-hidroxilasa |
ES2796530T3 (es) * | 2009-10-26 | 2020-11-27 | Prometheus Biosciences Inc | Ensayos para la detección de fármacos anti-TNF y autoanticuerpos |
CA3040276A1 (en) | 2009-12-02 | 2011-06-09 | Imaginab, Inc. | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
EP3450979A3 (en) | 2010-03-17 | 2019-04-24 | The Regents of The University of Michigan | Using phage epitopes to profile the immune response |
EP2569639B1 (en) | 2010-05-12 | 2015-02-11 | Hill's Pet Nutrition, Inc. | Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines |
US20130310266A1 (en) * | 2010-09-03 | 2013-11-21 | Immport Therapeutics, Inc. | Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders |
WO2012045279A1 (en) * | 2010-10-08 | 2012-04-12 | Shanghai Kexin Biotech Co., Ltd. | Moesin fragments associated with immune thrombocytopenia |
EA018848B1 (ru) * | 2010-10-20 | 2013-11-29 | Вадим Юльевич ШАНИН | Иммунологически активное вещество, способ его получения, биозонд на его основе и способ диагностики состояния здоровья с применением биозонда, фармацевтическая композиция и способ лечения с использованием фармацевтической композиции |
CN102125698A (zh) * | 2010-11-29 | 2011-07-20 | 昆明理工大学 | 具有正常免疫功能的小鼠移植肿瘤模型的建立方法 |
CA2840590C (en) | 2011-07-01 | 2018-09-04 | Inova Diagnostics, Inc. | Method for increasing specificity of diagnostic tests for autoimmune diseases |
HUE035999T2 (hu) | 2011-10-21 | 2018-06-28 | Augurex Life Sciences Corp | Citrullinezett 14-3-3 peptidekbõl származó antigének és azok alkalmazásai a reumatoid artritisz diagnózisában |
CN102590530B (zh) * | 2012-03-02 | 2014-06-25 | 常晓天 | Krt84自我免疫抗体作为诊断、检测类风湿性关节炎的诊断标记物的应用 |
CN104428674A (zh) * | 2012-04-24 | 2015-03-18 | 思研(Sri)国际顾问与咨询公司 | 前列腺癌和sar-cov的人血清生物标记物 |
US20150362497A1 (en) * | 2013-01-31 | 2015-12-17 | Arizona Board of Regents on behalf of Arizona Stat State University | Autoantibody Signature for the Early Detection of Ovarian Cancer |
CN103604923B (zh) * | 2013-10-22 | 2015-05-13 | 卫生部北京医院 | 检测抗甲状腺过氧化物酶和甲状腺球蛋白的天然双特异性抗体的试剂盒 |
RU2678135C1 (ru) * | 2014-02-05 | 2019-01-23 | Фуджиребио Диагностикс Аб | Композиция и способ для детектирования злокачественного неопластического заболевания |
GB201411060D0 (en) * | 2014-06-20 | 2014-08-06 | Oncimmune Ltd | Improved immunoassay method |
CN104356226B (zh) * | 2014-11-04 | 2017-03-29 | 青岛海兰深生物科技有限公司 | 一种检测血浆免疫标志物‑vegfr1自身抗体的抗原多肽及应用 |
MX2018001566A (es) | 2015-08-07 | 2019-04-25 | Imaginab Inc | Construcciones de union a antigeno para moleculas diana. |
JP6818753B2 (ja) * | 2015-12-11 | 2021-01-20 | サンフォード ヘルス | 乳癌治療を監視するための試薬及び方法 |
CN106053812B (zh) * | 2016-06-29 | 2017-12-08 | 厦门生迪生物技术有限公司 | 一种用于肝癌早期筛查和诊断的多种自身抗体联合检测elisa试剂盒 |
JP6334017B1 (ja) * | 2017-01-25 | 2018-05-30 | ファナック株式会社 | 誘導電動機の制御装置 |
WO2018147960A1 (en) | 2017-02-08 | 2018-08-16 | Imaginab, Inc. | Extension sequences for diabodies |
CN111108388A (zh) * | 2017-06-23 | 2020-05-05 | 昂西免疫德国有限公司 | 用于治疗癌症的免疫肿瘤学 |
WO2019152498A1 (en) * | 2018-02-01 | 2019-08-08 | Sedia Biosciences Corporation | A rapid quantitative assay to assess duration of infection |
KR20230068378A (ko) | 2020-07-14 | 2023-05-17 | 오엔씨이뮨리미티드 | 폐암에서 자가항체를 검출하기 위한 항원 조합의 용도 |
GB2600701A (en) | 2020-11-04 | 2022-05-11 | Oncimmune Ltd | Antibody assay |
CN112345755B (zh) * | 2020-09-23 | 2023-06-16 | 杭州凯保罗生物科技有限公司 | 乳腺癌的生物标志物及其应用 |
GB2622246A (en) | 2022-09-08 | 2024-03-13 | Oncimmune Germany Gmbh | Antibody assay |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ211453A (en) | 1984-03-22 | 1989-01-06 | Biotechnology Research Enterpr | Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides |
EP0236606B1 (en) | 1986-03-10 | 1992-06-24 | Imre Corporation | Immune complex assay |
US4925788A (en) * | 1986-10-24 | 1990-05-15 | Immunicon Corporation | Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor |
WO1989001153A1 (en) | 1987-07-24 | 1989-02-09 | Xoma Corporation | Methods for breast cancer detection |
US4937185A (en) | 1987-07-31 | 1990-06-26 | The Ohio State University Research Foundation | Detection of circulating antibodies to a cancer marker protein |
US7282345B1 (en) | 1989-08-04 | 2007-10-16 | Schering Ag | C-erbB-2 external domain: GP75 |
US5157020A (en) | 1990-05-24 | 1992-10-20 | Research Corporation Tech., Inc. | Synthetic senescent cell antigen |
DK9091D0 (da) | 1991-01-18 | 1991-01-18 | Novo Nordisk As | Fremgangsmaade til fremstilling af antistoffer |
DE4120412C1 (pl) * | 1991-06-20 | 1993-01-07 | Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De | |
US6280962B1 (en) | 1991-11-25 | 2001-08-28 | Yoreh Biotechnologies Ltd. | Whole blood/mitogen assay for the early detection of a subject with cancer and kit |
US6322989B1 (en) | 1991-11-25 | 2001-11-27 | Yoreh Biotechnologies, Ltd. | Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit |
PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
CA2118015A1 (en) | 1992-04-14 | 1993-10-28 | Jeffrey R. Marks | Method of detecting tumors containing complexes of p53 and hsp70 |
US5801005A (en) | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
US5763164A (en) | 1993-04-16 | 1998-06-09 | Northwestern University | Immunogenic cancer proteins and peptides and methods of use |
US5747268A (en) | 1993-04-22 | 1998-05-05 | Dade International Inc. | Tumor marker control |
CN1097252A (zh) * | 1993-07-03 | 1995-01-11 | 首钢总公司 | 多元同步标记分析法 |
US5744144A (en) | 1993-07-30 | 1998-04-28 | University Of Pittsburgh University Patent Committee Policy And Procedures | Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
US5721105A (en) | 1994-02-20 | 1998-02-24 | B.R.A.H.M.S. Diagnostica Gmbh | Method for the immunological determination of proteins and kit for carrying out the method |
JPH07294530A (ja) * | 1994-04-20 | 1995-11-10 | Nippon Igaku Rinshiyou Kensa Kenkyusho:Kk | 病原体に対する体液中の抗体検出法 |
CA2148971A1 (en) | 1994-05-26 | 1995-11-27 | Izak Bahar | Calibrator matrix |
EP0764030B1 (en) | 1994-06-24 | 2000-09-20 | Vladimir P. Torchilin | Composition containing autoantibodies for tumor therapy and prophylaxis |
IL110464A0 (en) | 1994-07-26 | 1994-10-21 | Univ Ramot | Novel proteins for the diagnosis, imaging, and therapy of human cancer |
US5561049A (en) | 1994-09-21 | 1996-10-01 | Behringwerke Ag | Method for detecting antibodies |
US5876728A (en) | 1995-02-15 | 1999-03-02 | Howard David Kass | Natural composition extracted from plants used in the treatment of cancer |
AUPN568095A0 (en) | 1995-09-27 | 1995-10-26 | Austin Research Institute, The | Anti-Galalpha(1,3)Gal antibody binding peptides |
GB9521544D0 (en) | 1995-10-20 | 1995-12-20 | Univ Dundee | Activation of P53 protein and therapeutic applications thereof |
JPH09189702A (ja) | 1996-01-09 | 1997-07-22 | Hitachi Chem Co Ltd | 抗ムチン抗体の測定法、癌の測定法及び癌診断薬 |
ATE283069T1 (de) | 1996-08-16 | 2004-12-15 | Univ Johns Hopkins Med | Melanomzellinien, welche immundominante melanomantigene teilen und verfahren zu deren anwendung |
CN1044092C (zh) * | 1997-02-26 | 1999-07-14 | 上海医科大学 | 抗原-抗体-重组dna复合型疫苗 |
WO1998055872A1 (en) | 1997-06-03 | 1998-12-10 | Amdl, Inc. | Immunoassay for the detection of cancer |
DE19805815C1 (de) | 1998-02-13 | 1999-11-11 | Ansgar W Lohse | Diagnostikum zum Erkennen der autoimmunen Hepatitis |
JP4083855B2 (ja) | 1998-02-16 | 2008-04-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 肺癌予後検査方法 |
GB9810040D0 (en) | 1998-05-11 | 1998-07-08 | Univ Nottingham | Blood borne tumour markers |
AUPP349098A0 (en) | 1998-05-13 | 1998-06-04 | South Eastern Sydney Area Health Service | A method of monitoring pancreatic tissue viability |
WO2000026668A2 (en) | 1998-11-05 | 2000-05-11 | The Regents Of The University Of Michigan | S100 proteins and autoantibodies as serum markers for cancer |
US6387639B1 (en) | 1998-11-10 | 2002-05-14 | Sloan-Kettering Institute For Cancer Research | Ma family polypeptides and anti-Ma antibodies |
GB9827228D0 (en) | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
US7807810B2 (en) | 1999-04-08 | 2010-10-05 | The Ohio State University Research Foundation | Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby |
US6645465B2 (en) | 1999-08-06 | 2003-11-11 | Michigan, University Of The Regents | Annexin proteins and autoantibodies as serum markers for cancer |
US20020064801A1 (en) * | 1999-12-01 | 2002-05-30 | Ryan Jeffrey R. | Novel and practical serological assay for the clinical diagnosis of leishmaniasis |
US6667160B2 (en) | 2000-03-15 | 2003-12-23 | Kenneth D. Fine | Method for diagnosing immunologic food sensitivity |
US20030232399A1 (en) | 2000-06-14 | 2003-12-18 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
US20030138860A1 (en) | 2000-06-14 | 2003-07-24 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
EP1354206A2 (en) | 2000-12-13 | 2003-10-22 | Bio-Rad Laboratories, Inc. | Standard diluent for multiplex assays |
US7745141B2 (en) | 2001-06-21 | 2010-06-29 | New York University | Mycobacterial proteins as early antigens for serodiagnosis and vaccines |
GB0128583D0 (en) * | 2001-11-28 | 2002-01-23 | Rsr Ltd | Detection of autoantibodies indicative of diabetes |
US20030049692A1 (en) * | 2002-09-16 | 2003-03-13 | Norman Latov | Detection of anti-glycolipid antibodies by latex agglutination assay |
GB2395270B (en) * | 2002-11-14 | 2006-08-16 | Univ Nottingham | Tumour marker proteins and uses thereof |
CN1547025A (zh) * | 2003-12-03 | 2004-11-17 | 刘春杰 | 高灵敏度酶联免疫分析检测试剂盒 |
JP2005352771A (ja) | 2004-06-10 | 2005-12-22 | Hitachi Software Eng Co Ltd | 発現プロファイルによるパターン認識システム |
US20060141547A1 (en) | 2004-11-16 | 2006-06-29 | Das Hasi R | Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis |
GB2426581A (en) | 2005-05-27 | 2006-11-29 | Univ Nottingham | Immunoassay methods |
WO2007032634A1 (en) | 2005-09-12 | 2007-03-22 | Industry Foundation Of Chonnam National University | A method for production of mature natural killer cell |
TWI304443B (en) | 2005-12-30 | 2008-12-21 | Nat Health Research Institutes | Alpha-enolase specific antibody and method of use |
CA2663154C (en) | 2006-09-13 | 2016-02-23 | Oncimmune Ltd | Improved immunoassay methods |
CN101632020B (zh) | 2006-09-13 | 2013-11-27 | 昂西免疫有限公司 | 改进的免疫测定方法 |
GB0725239D0 (en) | 2007-12-24 | 2008-02-06 | Oncimmune Ltd | Calibrator for autoantibody assay |
-
2005
- 2005-05-27 GB GB0510943A patent/GB2426581A/en not_active Withdrawn
-
2006
- 2006-05-26 ES ES10180756.8T patent/ES2458105T3/es active Active
- 2006-05-26 DE DE602006007703T patent/DE602006007703D1/de active Active
- 2006-05-26 DK DK10180756.8T patent/DK2275815T3/da active
- 2006-05-26 AT AT06744011T patent/ATE436018T1/de active
- 2006-05-26 PT PT101807568T patent/PT2275815E/pt unknown
- 2006-05-26 EP EP10180756.8A patent/EP2275815B1/en active Active
- 2006-05-26 US US11/814,516 patent/US8722339B2/en active Active
- 2006-05-26 PL PL09004778T patent/PL2073008T3/pl unknown
- 2006-05-26 PL PL06744011T patent/PL1889059T3/pl unknown
- 2006-05-26 WO PCT/GB2006/001944 patent/WO2006126008A2/en active Application Filing
- 2006-05-26 CA CA2609793A patent/CA2609793C/en not_active Expired - Fee Related
- 2006-05-26 MX MX2007014815A patent/MX2007014815A/es active IP Right Grant
- 2006-05-26 CN CN201210248279.6A patent/CN102749447B/zh active Active
- 2006-05-26 AU AU2006250923A patent/AU2006250923B2/en not_active Ceased
- 2006-05-26 ES ES06744011T patent/ES2328171T3/es active Active
- 2006-05-26 CN CN200680018335.XA patent/CN101203756B/zh active Active
- 2006-05-26 ES ES09004778T patent/ES2384935T3/es active Active
- 2006-05-26 PT PT09004778T patent/PT2073008E/pt unknown
- 2006-05-26 DK DK09004778.8T patent/DK2073008T3/da active
- 2006-05-26 DK DK06744011T patent/DK1889059T3/da active
- 2006-05-26 AT AT09004778T patent/ATE554386T1/de active
- 2006-05-26 RU RU2007149281/15A patent/RU2416095C2/ru active
- 2006-05-26 EP EP09004778A patent/EP2073008B1/en active Active
- 2006-05-26 KR KR1020077030551A patent/KR101400986B1/ko active IP Right Grant
- 2006-05-26 SI SI200631356T patent/SI2073008T1/sl unknown
- 2006-05-26 EP EP06744011A patent/EP1889059B1/en active Active
- 2006-05-26 JP JP2008512924A patent/JP4876127B2/ja active Active
-
2007
- 2007-12-27 NO NO20076656A patent/NO339224B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2073008T3 (pl) | Ulepszone sposoby prowadzenia testów immunologicznych | |
BRPI0707645B8 (pt) | métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano | |
WO2008135564A3 (en) | Assays | |
ATE476657T1 (de) | Vorhersage von letalität und detektion von schweren erkrankungen | |
EP3293522A3 (en) | Lipidomic biomarkers for identification of high-risk coronary artery disease patients | |
MX2007005053A (es) | Metodo para evaluar la enfermedad de alzheimer y reactivo de diagnostico. | |
ATE360809T1 (de) | Schnelltest für biologische substanzen mittels ftir | |
WO2006092729A3 (en) | Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals | |
EP1930445A4 (en) | KIT AND METHOD FOR DETECTING UROTHELIAL CANCER | |
DE602006014581D1 (de) | Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c | |
WO2008062048A3 (en) | Methods for optically detecting multiple analytes in a liquid sample with a compressible microfluidic device | |
ATE370414T1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
NZ592819A (en) | Thyroid analyte detection and measurement | |
WO2008122447A3 (en) | Dna methylation assay for the diagnosis or prognosis of medical conditions | |
PL1977244T3 (pl) | Rozróżnianie bakteryjnego i wirusowego zapalenia opon mózgowych | |
CY1109461T1 (el) | Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου | |
EP2444812A3 (en) | Improved immunoassay methods | |
ATE534037T1 (de) | Verwendung des proteins asc als marker für brustkrebs | |
WO2004085669A3 (en) | Identification and quantification of microbial species in a sample | |
DE602005010548D1 (de) | Verbessertes verfahren zur diagnose des akuten koronarsyndroms | |
EP1636587A4 (en) | DIAGNOSTIC KIT FOR LIVER CIRRHOSIS COMPRISING A SPECIFIC ANTIBODY OF A HUMAN PROTO-ONCOGEN PROTEIN | |
CY1115323T1 (el) | Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου | |
DK1297342T3 (da) | Metode til diagnostisk bestemmelse af Alzheimer's sygdom på basis af holo-transcobalamin II | |
GB0501564D0 (en) | Test for prion disease | |
CY1113688T1 (el) | Βελτιωμενες μεθοδοι ανοσοπροσδιορισμου |